tirzepatide fda approval for weight loss Grants a New Indication Obesity Management FDA approves new weight-loss drug

Projected US state-level prevalence of adult obesity and severe obesity

These patterns were first identified in clinical trials and continue to be monitored in real-world use for medicines such as Mounjaro and Zepbound, which also contain Tirzepatide

Summary: Adequate water intake whilst taking Mounjaro is essential to counteract fluid losses from gastrointestinal side effects and maintain overall health, with the NHS recommending 6-8 glasses (approximately 1.2 litres) daily as a baseline

In clinical studies, tirzepatide led to substantial weight loss and improved blood sugar control in people with excess weight and type 2 diabetes

Keywords: dual agonists, incretin based therapy, tirzepatide, type 2 diabetes, obesity, glucagon-like peptide-1 receptor agonists 1